Aspirin Exacerbated Respiratory Disease clinical trials

Explore recruiting aspirin exacerbated respiratory disease clinical trials.

Also recruiting in Europe

Aspirin Exacerbated Respiratory Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Long-term aspirin therapy as a predictor of decreased susceptibility to SARSCoV-2 infection in aspirin-exacerbated respiratory disease

Poland

Phase II and Phase III (Integrated) EU CTIS Study details

A randomized, double blind, placebo controlled, parallel group, 52­week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps

Poland, Denmark, France, Romania, Netherlands, Germany +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized, double blind, placebo controlled, parallel group, 52­week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps

Sweden, Portugal, Germany, Poland, Hungary, Netherlands +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Aspirin Exacerbated Respiratory Disease trials by city

Aspirin Exacerbated Respiratory Disease in Toronto Aspirin Exacerbated Respiratory Disease in Vancouver Aspirin Exacerbated Respiratory Disease in Montreal Aspirin Exacerbated Respiratory Disease in Calgary Aspirin Exacerbated Respiratory Disease in Edmonton Aspirin Exacerbated Respiratory Disease in Ottawa Aspirin Exacerbated Respiratory Disease in Winnipeg Aspirin Exacerbated Respiratory Disease in Quebec City Aspirin Exacerbated Respiratory Disease in Hamilton Aspirin Exacerbated Respiratory Disease in Kitchener Aspirin Exacerbated Respiratory Disease in London Aspirin Exacerbated Respiratory Disease in Halifax Aspirin Exacerbated Respiratory Disease in New York Aspirin Exacerbated Respiratory Disease in Los Angeles Aspirin Exacerbated Respiratory Disease in Chicago Aspirin Exacerbated Respiratory Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease